Understanding FDA Regulations for Dietary Supplements

If you’re a dietary supplement manufacturer, brand owner, contract manufacturer, or supplier, understanding the FDA’s regulatory framework isn’t just good practice—it’s critical for your business. The FDA regulates the entire lifecycle of dietary supplements, from ingredient approval to label claims to manufacturing practices.

This guide walks through the key FDA rules and expectations that industry stakeholders need to follow—from labeling and new dietary ingredients (NDIs) to compliance enforcement and market risk.

The FDA’s Role in the Dietary Supplement Industry

The U.S. Food and Drug Administration (FDA) oversees the dietary supplement industry under the Dietary Supplement Health and Education Act (DSHEA) of 1994, which set the groundwork for how supplements are regulated. Unlike drugs, dietary supplements don’t require pre-market approval—but that does not mean they are unregulated.

The FDA expects businesses to proactively ensure product safety, accurate labeling, and Good Manufacturing Practices (cGMPs). Failure to comply can result in warning letters, import alerts, or product recalls.

What the FDA Expects from Supplement Businesses

1. You’re Responsible for Product Safety—Before It Reaches Market

Under DSHEA, the burden of proof lies with the manufacturer or distributor to ensure the safety of their products. The FDA only steps in when safety issues arise post-market—but if you’re not proactively compliant, you’re already exposed to liability.

• Ingredient sourcing must follow strict documentation protocols
• Finished products must undergo quality and stability testing
• Any new dietary ingredient (NDI) must be submitted with evidence of safety at least 75 days prior to marketing

2. Labeling Must Be Accurate, Transparent, and DSHEA-Compliant

Labeling is one of the most scrutinized aspects of dietary supplements—and one of the most common reasons for FDA action.

Your labels must include:

• Product name and/or identity
• Statement of identity (“Dietary Supplement”)
• Net quantity of contents
• Supplement Facts panel (with accurate ingredient listing and amounts)
• Directions for use and recommended dosage
• Name and address of the manufacturer/distributor
• Expiration date
• Required disclaimers, such as:

“This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

Be cautious with structure/function claims—they must be truthful, substantiated, and submitted to FDA within 30 days of marketing.

3. Marketing Claims Are a High-Risk Area

FDA and FTC closely monitor marketing claims, especially in digital advertising and influencer content.

What you can’t say: Any claim that your product can prevent, treat, cure, or diagnose a disease is classified as a drug claim, not a supplement claim—and that’s a major red flag.

What you can say: Support for normal bodily functions, like “supports immune health” or “promotes healthy digestion,” as long as it’s scientifically substantiated.

Brands must:

• Maintain documentation for all claims made
• Monitor resellers and affiliates for noncompliant messaging
• Respond to FDA warning letters quickly and thoroughly if contacted

What You Need to Know About New Dietary Ingredients (NDIs)

If you’re introducing an ingredient that wasn’t marketed in the U.S. before October 15, 1994, it’s considered an NDI—and requires a formal NDI notification to the FDA.

This process includes:

• A detailed safety dossier (toxicology, human use data, etc.)
• A 75-day waiting period before going to market
• No FDA “approval”—just no objection means you’re clear to proceed

Many companies skip this step, putting themselves at risk of future regulatory action. If you’re unsure whether an ingredient qualifies as “new,” it’s critical to consult regulatory experts.

FDA Inspections and Compliance Enforcement

FDA inspections are unannounced and increasing in frequency, especially for facilities involved in contract manufacturing, packaging, and labeling.

To prepare:

• Follow 21 CFR Part 111 cGMPs for dietary supplements
• Keep records of batch production, testing, and quality control
• Ensure your Standard Operating Procedures (SOPs) are complete and up to date
• Train staff on label claim substantiation and change control

The FDA may issue:

• Form 483 observations during inspection
• Warning Letters for serious violations
• Import alerts blocking shipments
• Product recalls or seizures if the public is at risk

eCommerce and Global Distribution: New Risks, Same Rules

If you’re selling via Amazon, Shopify, or international marketplaces, don’t assume relaxed compliance standards apply.

• Amazon increasingly requires COAs, label reviews, and GMP documentation
• Foreign markets (EU, Canada, Australia) require additional registrations or approvals
• Cross-border shipments may be flagged by customs agencies for noncompliant labeling

Bottom Line: Regulatory Awareness Is a Business Advantage

Regulatory compliance isn’t just about avoiding fines—it’s about building a sustainable, trustworthy brand. Businesses that take FDA guidelines seriously gain:

• Fewer product disruptions
• Faster route to retail partnerships
• Stronger consumer trust
• Competitive advantage in a crowded market

The regulatory bar is rising. Make sure your business rises with it.

Need Help Staying Compliant?

PSC Software offers powerful digital solutions for quality management, document control, audit readiness, and regulatory compliance. Whether you’re preparing for FDA inspection or managing your supplement product lifecycle, we’re here to help.